Realistic illustration contrasting social stigma: neutral for overweight, positive for exercise weight loss, negative for Ozempic users.
AI द्वारा उत्पन्न छवि

Study finds people who use Ozempic-like drugs for weight loss face added stigma

AI द्वारा रिपोर्ट किया गया AI द्वारा उत्पन्न छवि तथ्य-जाँच किया गया

People who lose weight using GLP-1 medications such as Ozempic and Wegovy may be judged more negatively than those who lose weight through diet and exercise — and even more negatively than people who do not lose weight at all — according to a new study led by Rice University psychologist Erin Standen.

Buenos Aires Governor Axel Kicillof announced a boost in medication delivery across the province's 135 municipalities. The measure expands the Medicamentos Bonaerenses program following national cuts to the Remediar program. Kicillof sharply criticized the national government for underfunding health policies.

AI द्वारा रिपोर्ट किया गया

Germany's Gemeinsamer Bundesausschuss (G-BA) decided on Thursday to allow health insurers to cover four drugs that alleviate certain Long Covid symptoms. Previously, patients had to pay for these off-label uses themselves. The ruling eases access for the country's 74 million statutory insurees.

The U.S. Food and Drug Administration (FDA) and the European Medicines Agency have approved lenacapavir as pre-exposure prophylaxis (PrEP) for uninfected individuals at high risk. This antiretroviral drug is administered via subcutaneous injections every six months, providing an alternative to daily pills. The World Health Organization endorses its use in comprehensive prevention strategies.

AI द्वारा रिपोर्ट किया गया

In chile's presidential runoff, candidates like Jeannette Jara have revived ideas to eliminate vat on drugs and end oncology waiting lists. These proposals aim to ease the high cost of medications, which accounts for 60% of out-of-pocket health spending. Experts see a chance for agreements that go beyond the election.

यह वेबसाइट कुकीज़ का उपयोग करती है

हम अपनी साइट को बेहतर बनाने के लिए विश्लेषण के लिए कुकीज़ का उपयोग करते हैं। अधिक जानकारी के लिए हमारी गोपनीयता नीति पढ़ें।
अस्वीकार करें